Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT after budesonide versus placebo in active ulcerative colitis
NL-OMON52507Active, not recruiting
- Sponsor
- Vedanta Biosciences
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Randomised trial in autoimmune colitis comparing Budesonide pretreatment followed by FMT with Placebo pretreatment followed by FMT (2 arms). Started May 2019; status: active, not recruiting.
02
Drugs
budesonideallogeneic fecal microbiota
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on NL-OMON52507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52507.